The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease
Gaurav Goyal(Glocal University), Ronald S. Go(Mayo Clinic), Julio C. Sartori‐Valinotti(Mayo Clinic in Arizona), Mithun Vinod Shah(Mayo Clinic in Arizona), Robert Vassallo(Mayo Clinic), Jay H. Ryu(Mayo Clinic), Maria D. Hurtado(Jacksonville College), N. Nora Bennani(Mayo Clinic in Arizona), W. Oliver Tobin(Mayo Clinic), Jason R. Young(WinnMed), Karen L. Rech(Mayo Clinic in Arizona), Caroline Davidge‐Pitts(Mayo Clinic), Aishwarya Ravindran(Mayo Clinic in Arizona), Matthew J. Koster(Mayo Clinic in Arizona)
Cited by 190
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
|Journal of Clinical Oncology|2020|782
Review of the Comparative Pharmacology and Clinical Activity of Cisplatin and Carboplatin
|Journal of Clinical Oncology|1999|697